1. Home
  2. CGTX vs GROV Comparison

CGTX vs GROV Comparison

Compare CGTX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • GROV
  • Stock Information
  • Founded
  • CGTX 2007
  • GROV 2016
  • Country
  • CGTX United States
  • GROV United States
  • Employees
  • CGTX N/A
  • GROV N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • GROV Package Goods/Cosmetics
  • Sector
  • CGTX Health Care
  • GROV Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • GROV Nasdaq
  • Market Cap
  • CGTX 53.4M
  • GROV 53.5M
  • IPO Year
  • CGTX 2021
  • GROV N/A
  • Fundamental
  • Price
  • CGTX $2.41
  • GROV $1.54
  • Analyst Decision
  • CGTX Strong Buy
  • GROV Buy
  • Analyst Count
  • CGTX 3
  • GROV 2
  • Target Price
  • CGTX $2.83
  • GROV $1.35
  • AVG Volume (30 Days)
  • CGTX 12.4M
  • GROV 89.6K
  • Earning Date
  • CGTX 08-07-2025
  • GROV 08-07-2025
  • Dividend Yield
  • CGTX N/A
  • GROV N/A
  • EPS Growth
  • CGTX N/A
  • GROV N/A
  • EPS
  • CGTX N/A
  • GROV N/A
  • Revenue
  • CGTX N/A
  • GROV $185,354,000.00
  • Revenue This Year
  • CGTX N/A
  • GROV N/A
  • Revenue Next Year
  • CGTX N/A
  • GROV $11.10
  • P/E Ratio
  • CGTX N/A
  • GROV N/A
  • Revenue Growth
  • CGTX N/A
  • GROV N/A
  • 52 Week Low
  • CGTX $0.22
  • GROV $1.02
  • 52 Week High
  • CGTX $3.83
  • GROV $1.95
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 61.15
  • GROV 57.36
  • Support Level
  • CGTX $2.26
  • GROV $1.50
  • Resistance Level
  • CGTX $2.67
  • GROV $1.59
  • Average True Range (ATR)
  • CGTX 0.40
  • GROV 0.06
  • MACD
  • CGTX -0.03
  • GROV -0.00
  • Stochastic Oscillator
  • CGTX 42.08
  • GROV 72.17

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

Share on Social Networks: